Hipogonadotropik Hipogonadizm ve İnfertilite Yönetimi (Kallman Sendromu)

Kelberman D & Dattani MT. Hypothalamic and pituitary development: Novel insights into the aetiology. European Journal of Endocrinology, 2007; 157(suppl_1), S3–S14. doi.org/10.1530/EJE-07-0156.

Munro MG, Balen AH, Cho SH, et al. The FIGO ovulatory disorders classification system. Int J Gynecol Obstet. 2022;159:1-20. doi:10.1002/ijgo.143311.

Dandona P & Dhindsa S. Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. The Journal of Clinical Endocrinology and Metabolism, 2011; 96(9), 2643–2651. https://doi.org/10.1210/jc.2010-2724.

Boehm U, Bouloux PM, Dattani MT et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism-pathogenesis, diagnosis and treatment. Nature Reviews Endocrinology, 2015; 11(9), 547–564. https://doi.org/10.1038/nrendo.2015.112

Quinton R, Duke VM, Robertson A, et al. Idiopathic gonadotrophin deficiency: Genetic questions addressed through phenotypic characterization. Clinical Endocrinology, 2001; 55(2), 163–174. https://doi.org/10.1046/j.1365-2265.2001.01277.x

Dwyer A A, Raivio T, Pitteloud N. Management of endocrine disease: Reversible hypogonadotropic hypo gonadism. European Journal of Endocrinology, 2016; 174(6), R267–R274. https://doi.org/10.1530/EJE-15-1033.

Palmert MR, Dunkel L. Clinical practice. Delayed puberty. The New England of Journal Medicine. 2012 Feb 2;366(5):443-53. doi: 10.1056/NEJMcp1109290.

Bry-Gauillard H, Larrat-Ledoux F, Levaillant JM, et al. (2017). Anti-mullerianhormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism/ kallmann syndrome: Effects of recombinant human FSH. The Journal of

Clinical Endocrinology and Metabolism, 2017;102(4), 1102–1111.

https://doi.org/10.1210/jc.2016-3799.

Chan C, Liu K. Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH. Journal of Assisted Reproduction and Genetics. 2014 Oct;31(10):1317-21. doi: 10.1007/s10815-014-0312-2.

Silveira, LF, Latronico AC. Approach to the patient with hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology and Metabolism,2013; 98(5), 1781–1788. https://doi.org/10.1210/jc.2012-3550.

Martin K, Santoro N, Hall J, et al. Clinical review 15: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. Journal of Clinical Endocrinology and Metabolism. 1990 Nov;71(5):1081A-1081G. doi: 10.1210/jcem-71-5-1081.

Yasmin E, Davies M, Conway G,et al. British Fertility Society. 'Ovulation induction in WHO Type 1 anovulation: Guidelines for practice'. Produced on behalf of the BFS Policy and Practice Committee. Human Fertility, 2013; 16(4), 228–234. https://doi.org/10.3109/14647273.2013.829673.

Schoot DC, Harlin J, Shoham Z, et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Human Reproduction, 1994; 9(7), 1237–1242. https://doi.org/10.1093/oxfordjournals.humrep.a138685.

Salle A, Klein M, Pascal-Vigneron V, et al. Successful pregnancy and birth after sequential cotreatment with growth hormone and gonadotropins in a woman with panhypopituitarism: a new treatment protocol. Fertility and Sterility. 2000;74:1248–50

Green KA, Zolton JR, Schermerhorn SMV, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis. Fertility and Sterility. 2017;107:924–33.e5.

Jindal U, Jindal S. Ovulation induction in hypogonadotropic hypogonadism. In: Ghumman, S. (Ed.), Rinciples and practice of controlled ovarian stimulation in ART 2015; (pp. 357–368). Springer Nature.

Gao Y, Yu B, Mao J, et al. Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: A systematic review and meta-analysis. BMC Endocrine Disorders, 2018; 18(1), 85. https://doi.org/10.1186/s12902-018-0313-8.

Zhang CM, Zhang H, Yang R, et al. The Reproductive Outcome of Women with Hypogonadotropic Hypogonadism in IVF. Frontiers in Endocrinology (Lausanne). 2022 Jun 6;13:850126. doi: 10.3389/fendo.2022.850126.

Heidenberg RA, Ginsburg ES, Gordon CE, et al.In vitro fertilization cycle and embryo transfer outcomes in oligoanovulatory patients with hypothalamic hypogonadism vs. polycystic ovary syndrome and compared with normo-ovulatory patients. F&S reports, 2022; 3(3), 237–245. https://doi.org/10.1016/ j.xfre.2022.06.003

Shah D , Bansal S. Superovulation strategies in assisted conception. In: Rao KA, ed. Principles and Practice of Assisted Reproductive Technology. Delhi: Jaypee Publishers; 2014. p. :538-51.

Kelberman D & Dattani MT. Hypothalamic and pituitary development: Novel insights into the aetiology. European Journal of Endocrinology, 2007; 157(suppl_1), S3–S14. doi.org/10.1530/EJE-07-0156.

Munro MG, Balen AH, Cho SH, et al. The FIGO ovulatory disorders classification system. Int J Gynecol Obstet. 2022;159:1-20. doi:10.1002/ijgo.143311.

Dandona P & Dhindsa S. Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. The Journal of Clinical Endocrinology and Metabolism, 2011; 96(9), 2643–2651. https://doi.org/10.1210/jc.2010-2724.

Boehm U, Bouloux PM, Dattani MT et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism-pathogenesis, diagnosis and treatment. Nature Reviews Endocrinology, 2015; 11(9), 547–564. https://doi.org/10.1038/nrendo.2015.112

Quinton R, Duke VM, Robertson A, et al. Idiopathic gonadotrophin deficiency: Genetic questions addressed through phenotypic characterization. Clinical Endocrinology, 2001; 55(2), 163–174. https://doi.org/10.1046/j.1365-2265.2001.01277.x

Dwyer A A, Raivio T, Pitteloud N. Management of endocrine disease: Reversible hypogonadotropic hypo gonadism. European Journal of Endocrinology, 2016; 174(6), R267–R274. https://doi.org/10.1530/EJE-15-1033.

Palmert MR, Dunkel L. Clinical practice. Delayed puberty. The New England of Journal Medicine. 2012 Feb 2;366(5):443-53. doi: 10.1056/NEJMcp1109290.

Bry-Gauillard H, Larrat-Ledoux F, Levaillant JM, et al. (2017). Anti-mullerianhormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism/ kallmann syndrome: Effects of recombinant human FSH. The Journal of

Clinical Endocrinology and Metabolism, 2017;102(4), 1102–1111.

https://doi.org/10.1210/jc.2016-3799.

Chan C, Liu K. Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH. Journal of Assisted Reproduction and Genetics. 2014 Oct;31(10):1317-21. doi: 10.1007/s10815-014-0312-2.

Silveira, LF, Latronico AC. Approach to the patient with hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology and Metabolism,2013; 98(5), 1781–1788. https://doi.org/10.1210/jc.2012-3550.

Martin K, Santoro N, Hall J, et al. Clinical review 15: Management of ovulatory disorders with pulsatile gonadotropin-releasing hormone. Journal of Clinical Endocrinology and Metabolism. 1990 Nov;71(5):1081A-1081G. doi: 10.1210/jcem-71-5-1081.

Yasmin E, Davies M, Conway G,et al. British Fertility Society. 'Ovulation induction in WHO Type 1 anovulation: Guidelines for practice'. Produced on behalf of the BFS Policy and Practice Committee. Human Fertility, 2013; 16(4), 228–234. https://doi.org/10.3109/14647273.2013.829673.

Schoot DC, Harlin J, Shoham Z, et al. Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Human Reproduction, 1994; 9(7), 1237–1242. https://doi.org/10.1093/oxfordjournals.humrep.a138685.

Salle A, Klein M, Pascal-Vigneron V, et al. Successful pregnancy and birth after sequential cotreatment with growth hormone and gonadotropins in a woman with panhypopituitarism: a new treatment protocol. Fertility and Sterility. 2000;74:1248–50

Green KA, Zolton JR, Schermerhorn SMV, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis. Fertility and Sterility. 2017;107:924–33.e5.

Jindal U, Jindal S. Ovulation induction in hypogonadotropic hypogonadism. In: Ghumman, S. (Ed.), Rinciples and practice of controlled ovarian stimulation in ART 2015; (pp. 357–368). Springer Nature.

Gao Y, Yu B, Mao J, et al. Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: A systematic review and meta-analysis. BMC Endocrine Disorders, 2018; 18(1), 85. https://doi.org/10.1186/s12902-018-0313-8.

Zhang CM, Zhang H, Yang R, et al. The Reproductive Outcome of Women with Hypogonadotropic Hypogonadism in IVF. Frontiers in Endocrinology (Lausanne). 2022 Jun 6;13:850126. doi: 10.3389/fendo.2022.850126.

Heidenberg RA, Ginsburg ES, Gordon CE, et al.In vitro fertilization cycle and embryo transfer outcomes in oligoanovulatory patients with hypothalamic hypogonadism vs. polycystic ovary syndrome and compared with normo-ovulatory patients. F&S reports, 2022; 3(3), 237–245. https://doi.org/10.1016/ j.xfre.2022.06.003

Shah D , Bansal S. Superovulation strategies in assisted conception. In: Rao KA, ed. Principles and Practice of Assisted Reproductive Technology. Delhi: Jaypee Publishers; 2014. p. :538-51.